The kinetics of transcriptomic changes induced by cigarette smoke in rat lungs reveals a specific program of defense, inflammation, and circadian clock gene expression.

Gene expression profiling in animal models exposed to cigarette mainstream smoke (CS) shapes up as a promising tool for investigating the molecular mechanisms involved in the onset and development of CS-related disease and may aid in the identification of disease candidate genes. Here we report on differential gene expression in lungs of rats exposed for 2, 7, and 13 weeks to 300 and 600 microg total particulate matter/l CS with sacrifice 2, 6, or 20 h after the last exposure. Regarding antioxidant and xenobiotic-metabolizing (phase I/II) enzymes, a stereotypic, mostly transient, expression pattern of differentially expressed genes was observed after each exposure period. The expression patterns were generally dose dependent for antioxidant and phase II genes and not dose dependent for phase I genes at the CS concentrations tested. However, with increasing length of exposure, there was a distinct, mostly sustained and dose-sensitive, expression of genes implicated in innate and adaptive immune responses, clearly pointing to an emerging inflammatory response. Notably, this inflammatory response included the expression of lung disease-related genes not yet linked to CS exposure, such as galectin-3, arginase 1, and chitinase, as well as genes encoding proteolytic enzymes. Finally, our experiments also revealed a CS exposure-dependent shift in the cyclical expression of genes involved in controlling the circadian rhythm. Altogether, these results provide further insight into the molecular mechanisms of CS-dependent disease onset and development and thus may also be useful for defining CS-specific molecular biomarkers of disease.

[1]  P. Vanscheeuwijck,et al.  LUNG INFLAMMATION IN RATS FOLLOWING SUBCHRONIC EXPOSURE TO CIGARETTE MAINSTREAM SMOKE , 2006, Experimental lung research.

[2]  S. Gebel,et al.  Cigarette Smoke-Induced Redox Signaling and Gene Expression in In Vitro and In Vivo Models , 2006 .

[3]  A. Hengstermann,et al.  Characterization of Nrf2 activation and heme oxygenase-1 expression in NIH3T3 cells exposed to aqueous extracts of cigarette smoke. , 2005, Free radical biology & medicine.

[4]  Y. H. Yang,et al.  A distinctive alveolar macrophage activation state induced by cigarette smoking. , 2005, American journal of respiratory and critical care medicine.

[5]  H. Aburatani,et al.  Constitutive Expression of Aryl Hydrocarbon Receptor in Keratinocytes Causes Inflammatory Skin Lesions , 2005, Molecular and Cellular Biology.

[6]  P. Sassone-Corsi,et al.  Structural and functional features of transcription factors controlling the circadian clock. , 2005, Current opinion in genetics & development.

[7]  P. Sutphin,et al.  Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer , 2005, Oncogene.

[8]  Y. Takenaka,et al.  Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells. , 2005, Cancer research.

[9]  Neal L. Benowitz,et al.  Metabolism and Disposition Kinetics of Nicotine , 2005, Pharmacological Reviews.

[10]  Makoto Kobayashi,et al.  Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. , 2005, Antioxidants & redox signaling.

[11]  Irina Petrache,et al.  Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. , 2004, The Journal of clinical investigation.

[12]  M. Rothenberg,et al.  Arginine in asthma and lung inflammation. , 2004, The Journal of nutrition.

[13]  M. Carroll,et al.  The complement system in regulation of adaptive immunity , 2004, Nature Immunology.

[14]  B. Celli,et al.  Gene expression profiling of human lung tissue from smokers with severe emphysema. , 2004, American journal of respiratory cell and molecular biology.

[15]  Gang Liu,et al.  Effects of cigarette smoke on the human airway epithelial cell transcriptome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Jack A. Elias,et al.  Acidic Mammalian Chitinase in Asthmatic Th2 Inflammation and IL-13 Pathway Activation , 2004, Science.

[17]  Allan B. Okey,et al.  Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer* , 2004, Journal of Biological Chemistry.

[18]  I. Rahman Smoking-Induced Inflammation, Injury and Disease: Molecular Mechanisms , 2004 .

[19]  E. A. Kelly,et al.  Inflammatory changes associated with circadian variation in pulmonary function in subjects with mild asthma , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  A. Bosio,et al.  Gene expression profiling in respiratory tissues from rats exposed to mainstream cigarette smoke. , 2003, Carcinogenesis.

[21]  A. O’Regan The role of osteopontin in lung disease. , 2003, Cytokine & growth factor reviews.

[22]  K. Kadota,et al.  Genome-wide Expression Analysis of Mouse Liver Reveals CLOCK-regulated Circadian Output Genes* , 2003, Journal of Biological Chemistry.

[23]  P. Rouleau,et al.  Blockade of S100A8 and S100A9 Suppresses Neutrophil Migration in Response to Lipopolysaccharide 1 , 2003, The Journal of Immunology.

[24]  S. Theocharis,et al.  Metallothionein: A Multifunctional Protein from Toxicity to Cancer , 2003, The International journal of biological markers.

[25]  D. Vercelli,et al.  Arginase: marker, effector, or candidate gene for asthma? , 2003, The Journal of clinical investigation.

[26]  Qutayba Hamid,et al.  Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. , 2003, The Journal of clinical investigation.

[27]  David Siegel,et al.  Interaction of Human NAD(P)H:Quinone Oxidoreductase 1 (NQO1) with the Tumor Suppressor Protein p53 in Cells and Cell-free Systems* , 2003, The Journal of Biological Chemistry.

[28]  P. Fireman Understanding asthma pathophysiology. , 2003, Allergy and asthma proceedings.

[29]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[30]  J. Polak,et al.  CIGARETTE SMOKE DECREASES INDUCIBLE NITRIC OXIDE SYNTHASE IN LUNG EPITHELIAL CELLS , 2003, Experimental lung research.

[31]  R. Strong,et al.  The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. , 2002, Molecular cell.

[32]  K. Janda,et al.  A previously undescribed chemical link between smoking and metabolic disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  N. Benowitz,et al.  Cardiovascular Effects of Nasal and Transdermal Nicotine and Cigarette Smoking , 2002, Hypertension.

[34]  Stephan Gebel,et al.  Kinetics of gene expression profiling in Swiss 3T3 cells exposed to aqueous extracts of cigarette smoke. , 2002, Carcinogenesis.

[35]  J. Lotem,et al.  NQO1 stabilizes p53 through a distinct pathway , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Haussmann,et al.  Evaluation of the potential effects of ingredients added to cigarettes. Part 2: chemical composition of mainstream smoke. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[37]  S. Gebel,et al.  Evaluation of the potential effects of ingredients added to cigarettes. Part 4: subchronic inhalation toxicity. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[38]  Yi-hung Lin,et al.  The Osteopontin-CD44 Survival Signal Involves Activation of the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway* , 2001, The Journal of Biological Chemistry.

[39]  Jared Rutter,et al.  Regulation of Clock and NPAS2 DNA Binding by the Redox State of NAD Cofactors , 2001, Science.

[40]  H. Sano,et al.  The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins. , 2001, Biochemical and biophysical research communications.

[41]  C. Klaassen,et al.  Metallothionein transgenic and knock-out mouse models in the study of cadmium toxicity. , 1998, The Journal of toxicological sciences.

[42]  H. Haussmann,et al.  Comparison of fresh and room-aged cigarette sidestream smoke in a subchronic inhalation study on rats. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[43]  Riyao Yang,et al.  Expression of galectin-3 modulates T-cell growth and apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Gillette,et al.  Cholinergic regulation of the suprachiasmatic nucleus circadian rhythm via a muscarinic mechanism at night , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[45]  D. Yates,et al.  Acute and chronic effects of cigarette smoking on exhaled nitric oxide. , 1995, American journal of respiratory and critical care medicine.

[46]  C S Pittendrigh,et al.  Temporal organization: reflections of a Darwinian clock-watcher. , 1993, Annual review of physiology.

[47]  B. Tümmler,et al.  Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. , 1992, Immunobiology.

[48]  Alan D. Lopez,et al.  Mortality from tobacco in developed countries: indirect estimation from national vital statistics , 1992, The Lancet.

[49]  R. Magno,et al.  Coronary heart disease , 1957 .